PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 71 filers reported holding PASSAGE BIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,948 | -36.1% | 53,113 | -8.6% | 0.00% | – |
| Q2 2023 | $54,702 | -6.2% | 58,113 | -4.6% | 0.00% | – |
| Q1 2023 | $58,326 | -28.4% | 60,902 | +3.2% | 0.00% | – |
| Q4 2022 | $81,452 | +4.4% | 59,023 | -4.8% | 0.00% | – |
| Q3 2022 | $78,000 | -43.9% | 62,003 | +5.2% | 0.00% | – |
| Q2 2022 | $139,000 | -86.1% | 58,929 | -81.7% | 0.00% | – |
| Q1 2022 | $1,000,000 | -53.8% | 322,323 | -5.4% | 0.00% | – |
| Q4 2021 | $2,164,000 | -33.8% | 340,863 | +3.9% | 0.00% | -100.0% |
| Q3 2021 | $3,267,000 | -27.9% | 327,969 | -4.1% | 0.00% | 0.0% |
| Q2 2021 | $4,529,000 | -14.6% | 342,080 | +12.7% | 0.00% | 0.0% |
| Q1 2021 | $5,306,000 | -21.8% | 303,532 | +14.4% | 0.00% | 0.0% |
| Q4 2020 | $6,784,000 | +202.7% | 265,310 | +55.2% | 0.00% | – |
| Q3 2020 | $2,241,000 | +20.8% | 170,915 | +151.9% | 0.00% | – |
| Q2 2020 | $1,855,000 | – | 67,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $6,844,481 | 14.16% |
| Lynx1 Capital Management LP | 3,355,917 | $4,631,165 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $3,447,132 | 2.50% |
| BML Capital Management, LLC | 337,467 | $465,704 | 0.44% |
| Frazier Life Sciences Management, L.P. | 3,756,915 | $5,184,543 | 0.32% |
| Orbimed Advisors | 8,931,999 | $12,326,159 | 0.24% |
| Newtyn Management, LLC | 790,000 | $1,090,200 | 0.22% |
| Oasis Management Co Ltd. | 240,000 | $331,200 | 0.07% |
| Rubric Capital Management LP | 822,105 | $1,134,505 | 0.05% |
| Marquette Asset Management, LLC | 67,101 | $92,599 | 0.03% |